Literature DB >> 31779972

Maintenance therapy after allogeneic hematopoietic cell transplantation for acute myeloid leukemia.

Frederick R Appelbaum1.   

Abstract

With improvements in the safety of allogeneic hematopoietic cell transplantation, disease recurrence following the procedure is now the most frequent reason for treatment failure. Administration of maintenance therapy after transplantation is one way to try and prevent recurrence. This paper provides a brief review of the topic.
Copyright © 2019. Published by Elsevier Ltd.

Entities:  

Keywords:  5-azacytidine; AML; AZA; Acute myeloid leukemia; Adoptive immunotherapy; Allogeneic; FLT3 inhibitor; GVHD; GVL; Gilteritinib; Graft-versus-host disease; Graft-versus-leukemia; HCT; Hematopoietic cell transplantation; Hypomethylating agents; Maintenance; Midostaurin; Sorafenib

Mesh：

Year:  2019        PMID： 31779972     DOI： 10.1016/j.beha.2019.101109

Source DB:  PubMed          Journal:  Best Pract Res Clin Haematol        ISSN： 1521-6926            Impact factor:   3.020


  4 in total

1.  Impact of Conditioning Intensity and Genomics on Relapse After Allogeneic Transplantation for Patients With Myelodysplastic Syndrome.

Authors:  Laura W Dillon; Gege Gui; Brent R Logan; Mingwei Fei; Jack Ghannam; Yuesheng Li; Abel Licon; Edwin P Alyea; Asad Bashey; Steven M Devine; Hugo F Fernandez; Sergio Giralt; Mehdi Hamadani; Alan Howard; Richard T Maziarz; David L Porter; Erica D Warlick; Marcelo C Pasquini; Bart L Scott; Mitchell E Horwitz; H Joachim Deeg; Christopher S Hourigan
Journal:  JCO Precis Oncol       Date:  2021-01-25

2.  TKI Maintenance After Stem-Cell Transplantation for FLT3-ITD Positive Acute Myeloid Leukemia: A Systematic Review and Meta-Analysis.

Authors:  Nico Gagelmann; Christine Wolschke; Evgeny Klyuchnikov; Maximilian Christopeit; Francis Ayuk; Nicolaus Kröger
Journal:  Front Immunol       Date:  2021-03-12       Impact factor: 7.561

3.  Acute Myeloid Leukemia: From Biology to Clinical Practices Through Development and Pre-Clinical Therapeutics.

Authors:  Xavier Roussel; Etienne Daguindau; Ana Berceanu; Yohan Desbrosses; Walid Warda; Mathieu Neto da Rocha; Rim Trad; Eric Deconinck; Marina Deschamps; Christophe Ferrand
Journal:  Front Oncol       Date:  2020-12-09       Impact factor: 6.244

4.  A Pilot Study of Circulating Monocyte Subsets in Patients Treated with Stem Cell Transplantation for High-Risk Hematological Malignancies.

Authors:  Ida Marie Rundgren; Elisabeth Ersvær; Aymen Bushra Ahmed; Anita Ryningen; Øystein Bruserud
Journal:  Medicina (Kaunas)       Date:  2020-01-18       Impact factor: 2.430
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.